ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2022

Waiting for Actionable Evidence: Roflumilast or Azithromycin?

Jerry A Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.